{"id":5813,"date":"2016-09-26T11:44:27","date_gmt":"2016-09-26T15:44:27","guid":{"rendered":"http:\/\/www.thet3trader.com\/?p=5813"},"modified":"2018-06-06T16:08:45","modified_gmt":"2018-06-06T21:08:45","slug":"a-trump-vs-clinton-options-strategy","status":"publish","type":"post","link":"https:\/\/blog.t3live.com\/2016\/09\/26\/a-trump-vs-clinton-options-strategy\/","title":{"rendered":"A Trump vs. Clinton Options Strategy"},"content":{"rendered":"<p>Tonight we'll see the first US Presidential debate debate between Donald Trump and Hillary Clinton.<\/p>\n<p>I'm going to leave my personal opinions about both candidates out of this, and keep it focused on the markets.<\/p>\n<p>A major reason <strong>biotech<\/strong> (IBB) has rallied in recent weeks was Hillary Clinton's pneumonia diagnosis.<\/p>\n<p>Since she has been an outspoken critic of rising drug prices &#8212; specifically targeting <strong>Mylan's<\/strong> (MYL) Epipen &#8212; she is seen as an enemy of biotech and big pharma.<\/p>\n<p>Her illness boosted Trump in the polls, which in turn gave biotech a reprieve.<\/p>\n<p>That's perhaps a bit ironic, because Trump himself <span style=\"text-decoration: underline;\"><strong><a href=\"https:\/\/www.statnews.com\/2016\/07\/22\/donald-trump-pharma-doctor\/\">has been critical of drug company pricing practices<\/a><\/strong><\/span>.<\/p>\n<p>So heading into the debate, there appears to be a binary outcome &#8212; not between the candidates, but whether or now there is a decisive outcome.<\/p>\n<p>If it's a close call, that will just add to the confusion and the impact on stocks is a wash.<\/p>\n<p>But if one side scores a big victory, odds are these stocks move, at least in the early going.<\/p>\n<p>So I'd look at the following trades depending upon one's stance about the outcome:<\/p>\n<p>Benefits from a big Clinton or Trump victory:<\/p>\n<p>-Buy <strong>IBB<\/strong> $295 straddle expiring October 15 for $7 (give or take 10 cents)<\/p>\n<p>Benefits from a stalemate:<\/p>\n<p>-Sell\u00a0<strong>IBB<\/strong> weekly $285\/$290\/$300\/$305 iron condor expiring Friday for $1.88 (give or take 5 cents)<\/p>\n<p>I'd keep any positions small, and would look to close out either one tomorrow on the open.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tonight we&#8217;ll see the first US Presidential debate debate between Donald Trump and Hillary Clinton. I&#8217;m going to leave my personal opinions about both candidates out of this, and keep it focused on the markets. A major reason biotech (IBB) has rallied in recent weeks was Hillary Clinton&#8217;s pneumonia diagnosis. Since she has been an outspoken critic of rising drug prices &#8212; specifically targeting Mylan&#8217;s (MYL) Epipen &#8212; she is seen as an enemy of biotech and big pharma. Her illness boosted Trump in the polls, which in turn gave biotech a reprieve. That&#8217;s perhaps a bit ironic, because Trump himself has been critical of drug company pricing practices. So heading into the debate, there appears to be a binary outcome &#8212; not between the candidates, but whether or now there is a decisive outcome. If it&#8217;s a close call, that will just add to the confusion and the impact on stocks is a wash. But if one side scores a big victory, odds are these stocks move, at least in the early going. So I&#8217;d look at the following trades depending upon one&#8217;s stance about the outcome: Benefits from a big Clinton or Trump victory: -Buy IBB $295 straddle expiring October 15 for $7 (give or take 10 cents) Benefits from a stalemate: -Sell\u00a0IBB weekly $285\/$290\/$300\/$305 iron condor expiring Friday for $1.88 (give or take 5 cents) I&#8217;d keep any positions small, and would look to close out either one tomorrow on the open. &nbsp;<\/p>\n","protected":false},"author":6,"featured_media":5301,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,35,1],"tags":[267,315,30,54,270],"class_list":["post-5813","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-options-trading","category-uncategorized","tag-clinton","tag-hillary-clinton-biotech","tag-options","tag-options-trading","tag-trump"],"_links":{"self":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/posts\/5813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/comments?post=5813"}],"version-history":[{"count":1,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/posts\/5813\/revisions"}],"predecessor-version":[{"id":29378,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/posts\/5813\/revisions\/29378"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/media\/5301"}],"wp:attachment":[{"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/media?parent=5813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/categories?post=5813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.t3live.com\/wp-json\/wp\/v2\/tags?post=5813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}